Published ahead of print on August 1, 2002, doi:10.1164/rccm.200205-421OC
American Journal of Respiratory and Critical Care Medicine Vol 166. pp. 1099-1104, (2002)
© 2002 American Thoracic Society
Pulmonary Function Tests in Preschool Children with Cystic Fibrosis
Nicole Beydon,
Francis Amsallem,
Mireille Bellet,
Michèle Boulé,
Michèle Chaussain,
André Denjean,
Régis Matran,
Isabelle Pin,
Corinne Alberti and
Claude Gaultier the French Paediatric PHRC Group
Departments of Physiology and Public Health of the Robert Debré Teaching Hospital; Physiology Departments of the Saint-Vincent-de-Paul Teaching Hospital and Trousseau Teaching Hospital, Paris; Pediatric Department, Arnaud de Villeneuve Teaching Hospital, Montpellier; Physiology Department, Morvan Teaching Hospital, Brest; Poitiers Teaching Hospital, Poitiers; Calmette Teaching Hospital, Lille; and Grenoble Teaching Hospital, Grenoble, France
Correspondence and requests for reprints should be addressed to Claude Gaultier, Service de Physiologie, Hopital Robert Debré, 48 Bd Serurier, 75019, Paris, France. E-mail: claude.gaultier{at}rdb.ap-hop-paris.fr
ABSTRACT
Pulmonary function tests have rarely been assessed in preschool children with cystic fibrosis (CF). The objective of this multicenter study was to compare pulmonary function in 39 preschool children with CF (height, 90130 cm; 16 homozygous F508) and in 79 healthy control children. Functional residual capacity (helium dilution technique) and expiratory interrupter resistance (Rintexp) (interrupter technique) were measured. As compared with control children, children with CF had significantly higher Rintexp, expressed as absolute values and as Z-scores (1.05 ± 0.36 versus 0.80 ± 0.20 kPa·L-1 · second, p < 0.0001; and 1.31 ± 1.72 versus 0.19 ± 0.97, p < 0.0001), and significantly lower specific expiratory interrupter conductance (1.29 ± 0.34 versus 1.63 ± 0.43 kPa-1 · second, p < 0.0001). The effect of the bronchodilator salbutamol on Rintexp was not significantly different between children with CF and control children. Rintexp Z-scores were significantly higher in children with CF who were exposed to passive smoke (n = 8) (p < 0.03). Children with CF and with a history of respiratory symptoms (n = 31) had significantly higher functional residual capacity Z-scores (p < 0.02) and lower specific expiratory interrupter conductance Z-scores (p < 0.04). Genotype did not influence the data. We conclude that Rintexp and functional residual capacity measurements may help to follow young children with CF who are unable to perform reproducible forced expiratory maneuvers.
Key Words: functional residual capacity expiratory interrupter resistance bronchodilator genotype passive smoke
This article has been cited by other articles:

|
 |

|
 |
 
J. M. Collaco, L. Vanscoy, L. Bremer, K. McDougal, S. M. Blackman, A. Bowers, K. Naughton, J. Jennings, J. Ellen, and G. R. Cutting
Interactions Between Secondhand Smoke and Genes That Affect Cystic Fibrosis Lung Disease
JAMA,
January 30, 2008;
299(4):
417 - 424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Gangell, F. Horak Jr, H. J. Patterson, P. D. Sly, S. M. Stick, and G. L. Hall
Respiratory impedance in children with cystic fibrosis using forced oscillations in clinic
Eur. Respir. J.,
November 1, 2007;
30(5):
892 - 897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Thamrin, C. L Gangell, K. Udomittipong, M. M H Kusel, H. Patterson, T. Fukushima, A. Schultz, G. L Hall, S. M Stick, and P. D Sly
Assessment of bronchodilator responsiveness in preschool children using forced oscillations
Thorax,
September 1, 2007;
62(9):
814 - 819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Davis, A. S. Brody, M. J. Emond, L. C. Brumback, and M. Rosenfeld
Endpoints for Clinical Trials in Young Children with Cystic Fibrosis
Proceedings of the ATS,
August 1, 2007;
4(4):
418 - 430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. J. Terheggen-Lagro, H. G. M. Arets, J. van der Laag, and C. K. van der Ent
Radiological and functional changes over 3 years in young children with cystic fibrosis
Eur. Respir. J.,
August 1, 2007;
30(2):
279 - 285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Beydon, S. D. Davis, E. Lombardi, J. L. Allen, H. G. M. Arets, P. Aurora, H. Bisgaard, G. M. Davis, F. M. Ducharme, H. Eigen, et al.
An Official American Thoracic Society/European Respiratory Society Statement: Pulmonary Function Testing in Preschool Children
Am. J. Respir. Crit. Care Med.,
June 15, 2007;
175(12):
1304 - 1345.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Vilozni, L. Bentur, O. Efrati, T. Minuskin, A. Barak, A. Szeinberg, H. Blau, E. Picard, E. Kerem, Y. Yahav, et al.
Spirometry in Early Childhood in Cystic Fibrosis Patients
Chest,
February 1, 2007;
131(2):
356 - 361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M R Thomas, G F Rafferty, R Blowes, J L Peacock, N Marlow, S Calvert, A Milner, and A Greenough
Plethysmograph and interrupter resistance measurements in prematurely born young children
Arch. Dis. Child. Fetal Neonatal Ed.,
May 1, 2006;
91(3):
F193 - F196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. G. Nielsen, T. Pressler, B. Klug, C. Koch, and H. Bisgaard
Serial Lung Function and Responsiveness in Cystic Fibrosis during Early Childhood
Am. J. Respir. Crit. Care Med.,
June 1, 2004;
169(11):
1209 - 1216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Farrell, Z. Li, M. R. Kosorok, A. Laxova, C. G. Green, J. Collins, H.-C. Lai, M. J. Rock, and M. L. Splaingard
Bronchopulmonary Disease in Children with Cystic Fibrosis after Early or Delayed Diagnosis
Am. J. Respir. Crit. Care Med.,
November 1, 2003;
168(9):
1100 - 1108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Gibson, J. L. Burns, and B. W. Ramsey
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Am. J. Respir. Crit. Care Med.,
October 15, 2003;
168(8):
918 - 951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Beydon, I. Pin, R. Matran, M. Chaussain, M. Boule, B. Alain, M. Bellet, F. Amsallem, C. Alberti, A. Denjean, et al.
Pulmonary Function Tests in Preschool Children with Asthma
Am. J. Respir. Crit. Care Med.,
September 15, 2003;
168(6):
640 - 644.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2002
Am. J. Respir. Crit. Care Med.,
February 1, 2003;
167(3):
333 - 344.
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 American Thoracic Society
|
|
|